Shettle, L., McLaurin, E., Martel, J., Seaman, J. W., III, & Weissgerber, G. (2022). Topical Anti-TNF[alpha] Agent Licaminlimab Relieves Persistent Ocular Discomfort in Severe Dry Eye Disease: A Randomized Phase II Study. Clinical ophthalmology (Auckland, N.Z.), 16, 2167. https://doi.org/10.2147/OPTH.S366836
Citace podle Chicago (17th ed.)Shettle, Lee, Eugene McLaurin, Joseph Martel, John W. Seaman, III, a Georges Weissgerber. "Topical Anti-TNF[alpha] Agent Licaminlimab Relieves Persistent Ocular Discomfort in Severe Dry Eye Disease: A Randomized Phase II Study." Clinical Ophthalmology (Auckland, N.Z.) 16 (2022): 2167. https://doi.org/10.2147/OPTH.S366836.
Citace podle MLA (9th ed.)Shettle, Lee, et al. "Topical Anti-TNF[alpha] Agent Licaminlimab Relieves Persistent Ocular Discomfort in Severe Dry Eye Disease: A Randomized Phase II Study." Clinical Ophthalmology (Auckland, N.Z.), vol. 16, 2022, p. 2167, https://doi.org/10.2147/OPTH.S366836.